Results 91 to 100 of about 7,096 (184)

Biomarkers for satralizumab treatment in neuromyelitis optica spectrum disorders: a prospective case series. [PDF]

BMC Neurol
Hu S, Wang X, Wu H, Hong R, Xiao X, Zhao Y, Li R.   +6 more
europepmc   +1 more source

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders. [PDF]

Neurol Neuroimmunol Neuroinflamm
Niederschweiberer M, Panagiotaropoulou G, Fernandez-Viña MA, Montero-Martin G, Osoegawa K, Behne M, Franke A, Lieb W, Jarius S, Wildemann B, Schindler P, Otto C, Paul F, Flanagan EP, Cook LJ, Oksenberg J, Yeaman MR, Ripke S, Ruprecht K, Guthy-Jackson Charitable Foundation CIRCLES Study Group.   +19 more
europepmc   +1 more source

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders. [PDF]

Neurol Neuroimmunol Neuroinflamm
Xu Q, Zhang L, Duan X, Zhou K, Li Z, Yang X, Wang J, Jiang J, Xu K, Yu G, Zheng P, Li Y, Qin X, Li J, Wang WY, Zhao H, Huang D, Qu H, Xiao H, Li B, Wu L, Feng J.   +21 more
europepmc   +1 more source

Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis. [PDF]

Brain Behav
Ren J, Wang J, Niu Z, Guo J, Zhang N, Hao H, Gao F, Liu R, Wang Z.   +8 more
europepmc   +1 more source

Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders. [PDF]

Ann Neurol
Pu YL, Feng JZ, Meng HX, Xiao HB, Li XL, Zhen J, Lu WY, Xi XM, Wu T, Yuan BS, Fan ML, Zhang C, Tian DC, Meng X, Shi FD, Song T.   +15 more
europepmc   +1 more source

Peripheral blood immune inflammatory markers in neuromyelitis optica spectrum disorders. [PDF]

Front Neurol
Wu B, Cao F, Mao M, Gong X, Xu B.
europepmc   +1 more source

Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists. [PDF]

Mult Scler J Exp Transl Clin
Saposnik G, Solanes A, Monreal E, Sepúlveda M, Hernández MÁ, Cuello JP, Álvarez-Bravo G, Agüera-Morales E, Riancho J, Pérez-Sempere Á, Maurino J, Gómez-Ballesteros R.   +11 more
europepmc   +1 more source

Novel B-Cell targeting therapy with subcutaneous ofatumumab in AQP4-IgG-seronegative Neuromyelitis Optica Spectrum Disorders: efficacy and personalized dosing. [PDF]

Front Immunol
Cao X, Qin D, Wang B, Wang C, Guo S.
europepmc   +1 more source

Efficacy and Safety of Telitacicept and Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorders. [PDF]

Ann Indian Acad Neurol
Zuo S, Yang W, Wang X, Zhang M, Dong Z, Chen X, Li W.   +6 more
europepmc   +1 more source

Health Technology Assessment: Evaluation of Monoclonal Antibodies for the Treatment of Neuromyelitis Optica Spectrum Disorders. [PDF]

Drug Des Devel Ther
Wang C, Wu H, Huang Y, Liu A, Lai S.
europepmc   +1 more source